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AMPK and exercise 28 
In the late 1990s it was shown in vivo that skeletal muscle AMP-activated protein kinase 29 
(AMPK) activity is increased during exercise whilst pharmacological activation of 30 
AMPK could also increase skeletal muscle glucose uptake and free fatty acid (FFA) 31 
oxidation in vivo (22, 37). Taken together, these findings provided the impetus for the 32 
multitude of subsequent studies that have been undertaken to elucidate the role of AMPK 33 
in skeletal muscle metabolism. AMPK is a αβγ heterotrimer comprised of two α, two β, 34 
and three γ subunits (8). The α-subunits contain the catalytic domain responsible for 35 
activation which, during contraction, occurs via an increase in cellular stress due to 36 
increases in AMPfree and ADPfree levels. The increase in AMPfree allosterically activates 37 
AMPK, makes AMPK more susceptible to phosphorylation by upstream AMPK 38 
kinase(s), and the increase in AMPfree and ADPfree antagonizes the effect of protein 39 
phosphatases on AMPK, reducing the likelihood of dephosphorylation of AMPK (8, 40). 40 
AMPK is activated during moderate or harder exercise in humans (3, 6, 39) and there is 41 
evidence that AMPK phosphorylates and inactivates acetyl-CoA carboxylase (ACC)-β 42 
which is then thought to increase fat oxidation (37). However, AMPK cannot 43 
simultaneously act as a primary regulator of both glucose uptake and FFA oxidation 44 
during exercise because there are situations (e.g. increases in exercise intensity, pre- vs. 45 
post-training exercise, high vs. low carbohydrate diets) whereby increases in glucose 46 
uptake are accompanied by simultaneous decreases in fat oxidation, and vice-versa.  47 
Indeed, below I will discuss evidence that AMPK actually does not regulate either 48 





AMPK is not required for skeletal muscle glucose uptake during exercise 52 
Support for a role of AMPK in the regulation of skeletal muscle glucose uptake were 53 
initially derived from pharmacological studies whereby the cell permeable agent 5-54 
aminoimidazole-4-carboxamide-1-β-O-ribofuranoside (AICAR), an AMP mimetic, was 55 
shown to increase AMPK activity, Glut-4 translocation and glucose uptake (16, 22). 56 
However, it is important to note that whilst AICAR and contraction both activate AMPK 57 
and increase glucose uptake, this appears to be mediated via different pathways. While 58 
skeletal muscle glucose uptake in response to hypoxia/AICAR appears to be highly 59 
dependent on AMPK (7, 13, 25), as explained below there is evidence that this is not the 60 
case for contraction-stimulated glucose uptake. Thus, attempting to compare between 61 
AICAR, hypoxia, and contraction studies in relation to AMPK and glucose uptake can be 62 
problematic. 63 
 64 
Although skeletal muscle AMPK α2 activity activation and glucose uptake go hand in 65 
hand with increases in exercise intensity in humans (2) and rats (27), one cannot simply 66 
assume that this indicates a cause and effect relationship.  Indeed, most human and rodent 67 
studies have found clear dissociations between skeletal muscle AMPK activation and 68 
glucose uptake. Already in 2002 Wojtaszewski et al. (38) found increases in leg glucose 69 
uptake during the first hour of cycling at ~45% VO2peak, yet muscle AMPK α2 activity 70 
and AMPKαThr172 phosphorylation only significantly increased at the end of exercise 71 
(~3.5 hours). In addition, glucose uptake at the end of exercise was actually lower than 72 
earlier in exercise (38). Also, whole-body glucose uptake and skeletal muscle AMPK 73 
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activity increase 8-10 fold during prolonged cycling exercise at ~66% VO2 peak in 74 
untrained humans, but after just 10 days of exercise training there is no measurable 75 
increase in AMPK activity at all during the same absolute intensity of exercise in these 76 
individuals (19). The exercise training did attenuate the increase in glucose uptake during 77 
prolonged exercise, but it was still substantial, so if AMPK was playing a role one would 78 
expect some increase in skeletal muscle AMPK activity but none occurred (19). 79 
Similarly, there is no activation of skeletal muscle AMPK during 120 min of exercise at 80 
~65% VO2 peak in well trained endurance athletes (McConell et al. in review), despite 81 
substantial glucose uptake at this intensity in well trained individuals (34). It should be 82 
noted though that there may have been activation of some subunits of AMPK that were 83 
missed when only total AMPK activity is measured. Indeed, although increases in AMPK 84 
activity that occur before exercise training are totally nonexistent during exercise at the 85 
same relative intensity (~65% VO2 peak) after 12 weeks of exercise training, there is still 86 
20% of the pre-training increase in the AMPKα2β2γ3 trimer of AMPK during such 87 
exercise (24).  88 
 89 
Whole-body deletion of AMPK α1 or α2 fails to inhibit contraction-stimulated glucose 90 
uptake in vitro (13), whilst muscle glucose uptake during ex vivo contraction is either 91 
normal or only partially reduced in mice expressing a dominant-negative AMPK α2 92 
isoform (7, 23, 25, 35)). When interpreting these findings one should consider the 93 
potential confounding effects of knocking-out or suppressing AMPK or LKB1, such as 94 
alterations and/or compensation of enzymes upstream and/or downstream. For example, 95 
knocking-out AMPK α2 results in compensatory increases in AMPK α1 expression in 96 
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mouse skeletal muscle (15), whilst skeletal muscle of the AMPK α2 dominant-negative 97 
mouse has attenuated force generation ex vivo (7, 25). Importantly, muscle-specific 98 
AMPKα1α2 double knockout (mdKO) mice, which have only 3-4% of normal AMPK α2 99 
activity and no activation of AMPK during exercise, have normal increases in skeletal 100 
muscle glucose uptake during exercise at the same relative intensity (14). 101 
 102 
Some findings over the years have provided small indications that AMPK may play a role 103 
in glucose uptake with contraction in rodents but it is important to consider that these 104 
situations are often non physiological.  For example, it was shown that glucose uptake 105 
was lower during ex vivo twitch contractions in AMPKα1 KO mouse muscle than wild 106 
type mouse muscle and it was suggested that this may indicate that AMPKα1 plays a role 107 
in glucose uptake during short-duration low intensity exercise (11).  But AMPKα1 is 108 
usually not activated during short-duration low-moderate intensity exercise (40-70% VO2 109 
max) (6, 11, 26, 38, 39). 110 
 111 
A recent transgenic mouse study by Kjobsted et al. (14) convincingly showed that AMPK 112 
is not required for glucose uptake during contraction/exercise but rather is important for 113 
metabolism after exercise. Using muscle specific AMPKα1α2 double KO and inducible 114 
muscle specific AMPKα1α2 double KO mice, that have extremely low AMPK activity, 115 
they showed that glucose uptake was normal during ex vivo and in situ contraction. They 116 
also mentioned in the discussion (“unpublished observations”) that glucose uptake is 117 
normal in these mice during exercise (14). The authors said “We cannot ultimately rule 118 
out that AMPK may be necessary for regulating muscle glucose uptake during longer 119 
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periods of exercise (>30 min) and contraction (>10 min) where the myocellular stress 120 
may be further elevated” (14). However, as mentioned above, dissociations between 121 
glucose uptake and AMPK activation have been observed in humans during exercise 122 
lasting up to 3.5 hours (19, 38). 123 
An important point made by the authors of the recent rodent study (14) was that of the 10 124 
studies conducted previously that found impaired glucose uptake with contractions in 125 
AMPK-deficient mouse muscle, 8 of these actually examined the glucose uptake after, 126 
rather than during the contractions. As we pointed out previously in regards to a similar 127 
situation in studies examining the role of nitric oxide in glucose uptake with contraction 128 
(18), such study designs more investigate the effect of the intervention on glucose uptake 129 
after, than during, exercise.  130 
Therefore, it is clear from both mouse and human studies that AMPK is not required for 131 
glucose uptake during exercise. It is not possible however to discount it altogether 132 
however because there is likely redundancy in signalling to skeletal muscle glucose 133 
uptake during exercise.  134 
AMPK is not required for skeletal muscle fat oxidation during exercise 135 
In skeletal muscle, malonyl-CoA is believed to be a major factor involved in the 136 
regulation of FFA oxidation due to its inhibitory effects on carnitine palmitoyltranferase 137 
(CPT) 1, the main enzyme controlling fatty acid flux into the mitochondria for oxidation.  138 
Malonyl-CoA is synthesized by ACC-β, and skeletal muscle contraction and AMPK 139 
activation phosphorylates ACC-β at a serine residue (212 in rodents, 221 in humans) in 140 
skeletal muscle (2, 8, 31), and in vitro this phenomenon inhibits ACC-β (37). This has led 141 
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to the assumption that the activation of AMPK during exercise increases FFA oxidation 142 
due to AMPK phosphorylating and inhibiting ACC-β and thus reducing malonyl-CoA 143 
and removing the inhibition of CPT1.  However, as with glucose uptake, many 144 
dissociations have been observed between AMPK activation, ACC-β phosphorylation, 145 
ACC-β activity  and FFA oxidation during contraction and exercise. 146 
 147 
Low intensity exercise performed for ~3.5 hours in humans progressively increases 148 
skeletal muscle net FFA uptake and fat oxidation, despite the fact that ACC-β 149 
phosphorylation is only increased at 1hr, and AMPK activity and is only elevated at the 150 
end of exercise (38). Similarly, low intensity contraction increases FFA oxidation in rat 151 
skeletal muscle despite no alterations in AMPK or ACC-β activity (32). It has also been 152 
shown in humans that increasing exercise from moderate- to high-intensity results in a 153 
suppression of fat oxidation, but AMPK activity and ACC-β phosphorylation both 154 
increase (2) and ACC activity decreases (4). Furthermore, 10 days of exercise training in 155 
previously untrained individuals augments fat oxidation during prolonged exercise, yet 156 
skeletal muscle AMPK activity was not increased at all and ACC-β phosphorylation only 157 
increased slightly unlike larger increases during exercise before training (19).  158 
 159 
AMPK α2 DN mice, despite having very low AMPK activity, have normal increases in 160 
FAT/CD36 translocation to the plasma membrane (12), palmitate uptake (12) and fat 161 
oxidation (5) during contraction/exercise. Surprisingly, they also have normal increases 162 
in ACCβ phosphorylation (5) and reductions in malonyl CoA (5) during contraction. It 163 
has also been shown in perfused rat hindlimbs that fat uptake increases within one minute 164 
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of in situ contractions but AMPK is not activated until later (12). A study that did find a 165 
reduction in fat oxidation during ex vivo contraction of muscle specific AMPK a1α2 KO 166 
mice also found that these mice had reduced CD36 and FABPpm, important for fatty acid 167 
uptake and oxidation, which likely accounted for these findings (15).  Finally, there is 168 
evidence from skeletal muscle ACCβ Ser 212 knock in mice that ACCβ is important for 169 
AICAR-activated fatty acid oxidation at rest (30), but ACCβ is not required for fatty acid 170 
oxidation during ex vivo contraction or during treadmill exercise (29). Therefore, 171 
transgenic models support the human findings that there are dissociations between 172 
AMPK and fat oxidation during contractions and exercise.   173 
 174 
Conclusions 175 
In conclusion, although activation of AMPK during exercise appears to be critical for 176 
adaptations after exercise (10, 14, 17, 21, 28), AMPK activation is not necessary for 177 
increases in glucose uptake or fat oxidation during exercise. In 2005 George Brooks 178 
wrote “Now, with the results of McConell et al. (19). ….. it is time to reassess the 179 
relevance of the AMPK signalling pathway for the regulation of metabolism in working 180 
human muscle” (1). Despite this, 14 years later most papers related to AMPK still state in 181 
the introduction that AMPK regulates glucose uptake and fat oxidation during exercise. 182 
Although redundancy likely exists, it really is time to move on and look more closely at 183 
other possible regulators of glucose uptake and fat oxidation during exercise such as 184 
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